Alkhouri N - Search Results

1

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials.

Harrison SA, Wong VW, Okanoue T, Bzowej N, Vuppalanchi R, Younes Z, Kohli A, Sarin S, Caldwell SH, Alkhouri N, Shiffman ML, Camargo M, Li G, Kersey K, Jia C, Zhu Y, Djedjos CS, Subramanian GM, Myers RP, Gunn N, Sheikh A, Anstee QM, Romero-Gomez M, Trauner M, Goodman Z, Lawitz EJ, Younossi Z; STELLAR-3 and STELLAR-4 Investigators. Harrison SA, et al. Among authors: alkhouri n. J Hepatol. 2020 Jul;73(1):26-39. doi: 10.1016/j.jhep.2020.02.027. Epub 2020 Mar 6. J Hepatol. 2020. PMID: 32147362 Clinical Trial.

2

An apoptosis panel for nonalcoholic steatohepatitis diagnosis.

Tamimi TI, Elgouhari HM, Alkhouri N, Yerian LM, Berk MP, Lopez R, Schauer PR, Zein NN, Feldstein AE. Tamimi TI, et al. Among authors: alkhouri n. J Hepatol. 2011 Jun;54(6):1224-9. doi: 10.1016/j.jhep.2010.08.023. Epub 2011 Feb 12. J Hepatol. 2011. PMID: 21145805 Free PMC article.

3

Development and validation of a new histological score for pediatric non-alcoholic fatty liver disease.

Alkhouri N, De Vito R, Alisi A, Yerian L, Lopez R, Feldstein AE, Nobili V. Alkhouri N, et al. J Hepatol. 2012 Dec;57(6):1312-8. doi: 10.1016/j.jhep.2012.07.027. Epub 2012 Aug 4. J Hepatol. 2012. PMID: 22871498

4

Noninvasive Diagnosis of NASH and Liver Fibrosis Within the Spectrum of NAFLD.

Alkhouri N, McCullough AJ. Alkhouri N, et al. Gastroenterol Hepatol (N Y). 2012 Oct;8(10):661-8. Gastroenterol Hepatol (N Y). 2012. PMID: 24683373 Free PMC article.

5

Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.

Mohamad B, Shah V, Onyshchenko M, Elshamy M, Aucejo F, Lopez R, Hanouneh IA, Alhaddad R, Alkhouri N. Mohamad B, et al. Among authors: alkhouri n. Hepatol Int. 2016 Jul;10(4):632-9. doi: 10.1007/s12072-015-9679-0. Epub 2015 Nov 11. Hepatol Int. 2016. PMID: 26558795

6

The development of a non-invasive model to predict the presence of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease.

Goh GB, Issa D, Lopez R, Dasarathy S, Dasarathy J, Sargent R, Hawkins C, Pai RK, Yerian L, Khiyami A, Pagadala MR, Sourianarayanane A, Alkhouri N, McCullough AJ. Goh GB, et al. Among authors: alkhouri n. J Gastroenterol Hepatol. 2016 May;31(5):995-1000. doi: 10.1111/jgh.13235. J Gastroenterol Hepatol. 2016. PMID: 26589761

7

Treating nonalcoholic steatohepatitis in children: Not a cinch task.

Alkhouri N, Feldstein AE. Alkhouri N, et al. Hepatology. 2017 Apr;65(4):1407-1409. doi: 10.1002/hep.29043. Hepatology. 2017. PMID: 28073147 No abstract available.

8

Novel treatments for chronic hepatitis C: closing the remaining gaps.

Alkhouri N, Lawitz E, Poordad F. Alkhouri N, et al. Curr Opin Pharmacol. 2017 Dec;37:107-111. doi: 10.1016/j.coph.2017.10.001. Epub 2017 Nov 6. Curr Opin Pharmacol. 2017. PMID: 29121533 Review.

9

The utility of noninvasive scores in assessing the prevalence of nonalcoholic fatty liver disease and advanced fibrosis in type 1 diabetic patients.

Singh A, Le P, Lopez R, Alkhouri N. Singh A, et al. Among authors: alkhouri n. Hepatol Int. 2018 Jan;12(1):37-43. doi: 10.1007/s12072-017-9840-z. Epub 2018 Jan 9. Hepatol Int. 2018. PMID: 29318450

10

The search for noninvasive methods to identify liver fibrosis in children with nonalcoholic fatty liver disease.

Mandelia C, Kabbany MN, Conjeevaram Selvakumar PK, Alkhouri N. Mandelia C, et al. Among authors: alkhouri n. Biomark Med. 2018 Mar;12(3):265-273. doi: 10.2217/bmm-2017-0038. Epub 2018 Mar 8. Biomark Med. 2018. PMID: 29517271 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

258 results

Search Page